SCHEMBL6613428

SCHEMBL6613428

COc1cc(-c2cc(=O)c3ccc(O)c(O)c3o2)cc(OC)c1O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 10/20 0.81
ALDH1A1 P00352 4/20 0.64
CYP3A4 P08684 4/20 0.64
MAPT P10636 4/20 0.64
HPGD P15428 4/20 0.64
CYP2C9 P11712 3/20 0.64
CYP2C19 P33261 3/20 0.64
KDM4E B2RXH2 3/20 0.64
ALOX15 P16050 3/20 0.64
HSD17B10 Q99714 3/20 0.64
TP53 P04637 2/20 0.64
MAPK1 P28482 2/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
BRD4 O60885 1/20 0.64
IKBKB O14920 1/20 0.64
CYP19A1 P11511 1/20 0.64
MAOA P21397 1/20 0.64
MAOB P27338 1/20 0.64
NTRK2 Q16620 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6802044 0.92 TERT (0.77) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6613017 0.91 TERT (0.88) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL1778286 0.90 TERT (1.00) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6614126 0.87 TERT (1.00) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6612829 0.84 TERT (0.86) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6614508 0.84 TERT (0.73) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6804531 0.83 TERT (0.81) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6803222 0.82 TERT (0.74) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6613454 0.82 TERT (1.00) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL10305800 0.81 AKR1B1 (0.64) TERTALDH1A1CYP3A4MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 US disclosed
EP-1373244-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-02 EP disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 US disclosed
WO-2002074036-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885ALDH1A1 1247/4885CYP3A4 3385/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885ALDH1A1 1265/4885CYP3A4 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.